0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$0.51
0.00%
(0.00) 1D
Okt 16, 4:08:14 PM GMT+8 · HKD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 0775...
Buksan
HK$0.51
Mataas
HK$0.52
Mababa
HK$0.51
Mkt. cap
4.90B
Avg. na dami
1.66M
Dami
956.00K
Mataas nang 52-wk
HK$1.02
Mababa nang 52-wk
HK$0.51
EPS
-HK$0.01
Mga natitirang share
9.61B
Bilang ng mga empleyado
2K
Buksan
HK$0.51
Mataas
HK$0.52
Mababa
HK$0.51
Mkt. cap
4.90B
Avg. na dami
1.66M
Dami
956.00K
Mataas nang 52-wk
HK$1.02
Mababa nang 52-wk
HK$0.51
EPS
-HK$0.01
Mga natitirang share
9.61B
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Benzinga
·
4 oras ang nakalipas
Stock Market: Will S&P 500 Open Up or Down Today?
Bloomberg.com
·
13 oras ang nakalipas
Stocks Rebound From Chip Rout as Earnings Await: Markets Wrap
24/7 Wall St.
·
5 araw ang nakalipas
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
MarketWatch
·
1 buwan ang nakalipas
Bloom Energy was just named to the S&P 500. These other stocks are joining the index as well.
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
Tungkol sa CK Life Sciences Intl (Holdings) Inc